Brief: Mayne Pharma Says Directors Unanimously Recommend Shareholders Vote In Favour Of Scheme
05/06/2025 02:01
June 5 (Reuters) - Mayne Pharma Group Ltd MYX.AX: DIRECTORS UNANIMOUSLY RECOMMEND SHAREHOLDERS VOTE IN FAVOUR OF SCHEME POSITION IS TERMINATION NOTICE NOT EFFECTIVE, MATTERS IN COSETTE ADDITIONAL NOTICE WILL NOT GIVE RISE TO RIGHT TO TERMINATE SID HAS COMMENCED PROCEEDINGS WHICH WILL DETERMINE WHETHER OR NOT THE SID HAS BEEN VALIDLY TERMINATED PURSUING LITIGATION TO ESTABLISH SID REMAINS BINDING IS IN BEST INTEREST OF SHAREHOLDERS INTENDS TO PROCEED WITH THE SCHEME MEETING CONVENED FOR 18 JUNE Further company coverage: MYX.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mayne Pharma
See all newsBrief: Mayne Pharma Group Says It Settles Us Patent Litigation Re Imvexxy With Teva USA
Deals of the day-Mergers and acquisitions
Brief: Mayne Pharma Says Supreme Court Dismisses Cosette Appeal
Deals of the day-Mergers and acquisitions
Australian court dismisses Cosette appeal to drop Mayne Pharma takeover (updated)